HIMS

Q: What is the price of Hims Hers Health Inc (HIMS) today?

The price of Hims Hers Health Inc (HIMS) today is $ 24.77, with return of -25.26% compared to the last year. The price of Hims Hers Health Inc (HIMS) started the year trading around $ 32.47 and today it is at $ 24.77. Follow the real-time price chart, the historical price of Hims Hers Health Inc (HIMS) and international markets.

Q: When does Hims Hers Health Inc (HIMS) pay dividends?

Hims Hers Health Inc (HIMS) did not distribute dividends in the last year.

Q: Is Hims Hers Health Inc (HIMS) worth it?

Currently, Hims Hers Health Inc (HIMS) is priced at $ 24.77, with a P/E of 47.87%, representing a deviation of 1,176% from its historical average P/E. In the last year, the stock showed a variation of -25.26 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -25.26%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Hims Hers Health Inc (HIMS) stock?

Investing in stocks of Hims Hers Health Inc (HIMS) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Hims Hers Health Inc (HIMS) yield today?

The yield of Hims Hers Health Inc (HIMS) was 51.96% in the last month, -25.26% in the last year and 58.48% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Hims Hers Health Inc (HIMS) today, the total investment would be $ 2,477.00, based on the current price of $ 24.77.If past performance were to repeat, the return on your investment would be:In 1 year: $ 1,851.31In 5 years: $ 3,925.55In 10 years: $ 2,477.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Hims Hers Health Inc

Price

$ 24.77

return (12m)

-25.26%

p/e

47.87

p/bv

11.36

DIVIDEND YIELD

0.00%

HIMS price

HIMS

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment HIMS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

51.96%

3 months

-31.67%

1 year

-25.26%

2 years

57.97%

5 years

58.48%

10 years

0.00%

Fundamentals HIMS

review the fundamentals of Hims Hers Health Inc shares

P/E

47.87

Sector: 4.31 Industry: 4.31

P/S (PSR)

2.62

Sector: 1.88 Industry: 1.88

P/BV

11.36

Sector: 1.79 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: 0.46% Industry: 0.46%

ROA

5.96%

Sector: -5.61% Industry: -5.61%

ROE

23.73%

Sector: -3.30% Industry: -3.30%

ROIC

Sector: -145.17% Industry: -145.17%

NET MARGIN

5.47%

Sector: -8.06% Industry: -8.06%

GROSS MARGIN

69.65%

Sector: 25.93% Industry: 25.93%

OPERATING MARGIN

4.65%

Sector: -5.51% Industry: -5.51%

EV/EBITDA

107.25

Sector: -1,360.72 Industry: -1,360.72

EV/EBIT

2,197.12

Sector: -19.85 Industry: -19.85

PRICE-TO-ASSETS

2.85

Sector: 0.84 Industry: 0.84

BVPS

2.18

Sector: 7.51 Industry: 7.51

EPS

0.52

Sector: 0.17 Industry: 0.17

EQUITY-TO-ASSETS RATIO

0.25

Sector: 0.35 Industry: 0.35

LIABILITIES / ASSETS

0.75

Sector: 0.45 Industry: 0.45

CAGR REVENUE 5 YEARS

53.90%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Hims Hers Health Inc ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 24.77

Fair Value

$ 0.00

Upside/Downside Return potential.

-79.61%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HIMS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
META	25.62	7.13	27.83%	0.34%	$ 1.55 T	30.08%
INTR	14.46	1.81	12.49%	1.45%	$ 3.44 B	15.62%
PBR	5.95	1.57	26.37%	7.96%	$ 119.67 B	22.13%
VALE	26.64	1.82	6.85%	9.46%	$ 62.67 B	6.12%
PLTR	221.73	48.12	21.70%	0.00%	$ 360.32 B	36.31%
SHEL	14.66	1.49	10.17%	3.20%	$ 261.40 B	6.68%
BDORY	10.40	0.73	6.98%	5.04%	$ 25.75 B	9.30%
MAIN	10.01	1.65	16.48%	7.21%	$ 4.94 B	83.37%
ENB	21.93	2.49	11.38%	5.04%	$ 117.89 B	11.49%
NSRGY	11.21	6.32	56.41%	3.33%	$ 262.24 B	10.91%
PBR-A	5.38	1.42	26.37%	6.74%	$ 108.13 B	22.13%
ITUB	11.49	2.37	20.61%	3.06%	$ 93.34 B	27.17%
UNH	21.20	2.51	11.85%	3.09%	$ 255.57 B	2.69%
BBSEY	7.98	6.85	85.85%	11.94%	$ 13.04 B	100.00%
SAN	10.35	1.27	12.24%	1.98%	$ 167.23 B	23.74%
TTE	13.98	1.56	11.17%	5.49%	$ 183.54 B	7.20%
RACE	32.13	0.00	0.00%	0.94%	$ 58.74 B	22.35%
TD	9.99	1.72	17.19%	3.23%	$ 156.64 B	34.54%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

HIMS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Hims Hers Health Inc

Hims Hers Health Inc

Average Investor10 user rating

5.0 (46 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Hims & Hers Health, Inc. operates in the healthcare sector, focusing on digital health and direct-to-consumer (DTC) telemedicine services. Founded in 2017 and headquartered in San Francisco, California, the company provides online access to medical consultations, prescription treatments and wellness products through an integrated digital platform.

The business model combines telehealth services, licensed healthcare providers and pharmacy fulfillment to deliver treatments directly to consumers.

Its main areas of activity include:

• Telemedicine consultations through digital platforms.
• Prescription treatments for hair loss, dermatology and sexual health.
• Mental-health services, including therapy and psychiatric support.
• Personalized wellness products and subscription-based healthcare programs.

Hims & Hers primarily serves the United States, with services available across all states and the District of Columbia, while also maintaining a presence in the United Kingdom.

The company’s platform connects patients with licensed healthcare professionals, enabling remote consultations and treatment plans supported by partner pharmacies and fulfillment infrastructure.

Industry dynamics are influenced by the rapid adoption of telemedicine, increased consumer demand for personalized healthcare solutions and the expansion of subscription-based healthcare models. Competition includes digital health platforms, telemedicine providers and healthcare technology companies offering remote consultation services.

Shares of Hims & Hers Health, Inc. trade on the Nasdaq under the ticker HIMS.

History and Development

Hims & Hers Health, Inc. was founded in 2017 by Andrew Dudum, Jack Abraham and Hilary Coles with the objective of expanding access to healthcare treatments through digital platforms.

The company initially focused on online treatments for hair loss and dermatology, offering remote consultations and prescription delivery directly to consumers.

As the platform expanded, new services were introduced in areas such as sexual health, mental health and hormone therapy, broadening the scope of its digital healthcare ecosystem.

A major milestone occurred in 2021, when the company became publicly traded through a business combination with Oaktree Acquisition Corp., resulting in its listing on the Nasdaq under the ticker HIMS.

In recent years, Hims & Hers has expanded its treatment portfolio, increased subscription-based services and invested in technology infrastructure designed to support scalable telehealth operations and personalized healthcare delivery.

Additional Information

The Company Hims Hers Health Inc (United States), is listed on Nasdaq with a market value of $ 6.15 Billions, having an equity of $ 540.93 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 2.35 Billions, which generated a profit in the amount of $ 128.37 Millions.

As for its main indicators, the Company has a P/E ratio of 47.87, a P/BV ratio of 11.36 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker HIMS.

Market cap

$ 6.15 Billions

Net worth

$ 540.93 Millions

US$ 540,928,000.00

Assets

$ 2.15 Billions

US$ 2,154,705,000.00

Total Shares Outstanding

248.10 Millions

248,096,000

Average Daily Trading Volume

$ 19.54 Millions

US$ 19,535,118.00

Sector

Others

Industry

Others

HIMS

HIMS revenue and profits

Financial Results HIMS

DRAG THE FRAME TO SEE MORE DATA

HIMS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

SHG - Shinhan Financial Group Co Ltd

$ 58.79 87,12% (12M)

P/E

0.01

2.52%

ROE

0.00%

P/BV

0.00

VET - Vermilion Energy Inc.

$ 11.79 60,39% (12M)

P/E

-0.50

3.15%

ROE

0.00%

P/BV

0.00

UNH - UnitedHealth Group Incorporated

$ 282.09 --40,39% (12M)

P/E

21.20

3.09%

ROE

11.85%

P/BV

2.51

ALIZY - Allianz SE ADR

$ 40.42 9,23% (12M)

P/E

2.46

4.22%

ROE

71.63%

P/BV

1.76

STLA - Stellantis NV

$ 6.50 --43,23% (12M)

P/E

-0.93

10.99%

ROE

-32.04%

P/BV

0.30

COR - Cencora Inc.

$ 349.95 36,58% (12M)

P/E

41.77

0.66%

ROE

77.54%

P/BV

32.39

CRERF - Carrefour SA

$ 17.40 42,83% (12M)

P/E

3.66

7.40%

ROE

14.24%

P/BV

0.52

BLSH - Bullish

$ 36.62 --47,54% (12M)

P/E

-7.23

0.00%

ROE

-23.69%

P/BV

1.71